Clinicopathological analysis of hepatocellular adenoma according to new Bordeaux classification

Report of eight Korean cases

Hyunchul Kim, Ja June Jang, Dong-Sik Kim, Beom Woo Yeom, Nam Hee Won

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Hepatocellular adenoma (HCA) is a rare benign tumor of the liver. A subtype classification of HCA (hepatocyte nuclear factor 1α [HNF1α]-mutated, β-catenin-mutated HCA, inflammatory HCA, and unclassified HCA) has recently been established based on a single institutional review of a HCA series by the Bordeaux group. Methods: We used histologic and immunohistochemical parameters to classify and evaluate eight cases from our institution. We evaluated the new classification method and analyzed correlations between our results and those of other reports. Results: Seven of our eight cases showed histologic and immunohistochemical results consistent with previous reports. However, one case showed overlapping histologic features, as previously described by the Bordeaux group. Four cases showed glutamine synthetase immunohistochemical staining inconsistent with their classification, indicating that glutamine synthetase staining may not be diagnostic for ß-catenin-mutated HCA. HNF1α-mutated HCA may be indicated by the absence of liver fatty acid binding protein expression. Detection of amyloid A may indicate inflammatory HCA. HCA with no mutation in the HNF1α or β-catenin genes and no inflammatory protein expression is categorized as unclassified HCA. Conclusions: Although the new classification is now generally accepted, validation through follow-up studies is necessary.

Original languageEnglish
Pages (from-to)411-417
Number of pages7
JournalKorean Journal of Pathology
Volume47
Issue number5
DOIs
Publication statusPublished - 2013 Nov 19

Fingerprint

Liver Cell Adenoma
Hepatocyte Nuclear Factor 1
Catenins
Glutamate-Ammonia Ligase
Staining and Labeling
Fatty Acid-Binding Proteins
Amyloid

Keywords

  • Adenoma
  • Beta catenin
  • Hepatocyte nuclear factor 1-alpha
  • Liver cell
  • Serum amyloid A protein
  • Subtype

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Clinicopathological analysis of hepatocellular adenoma according to new Bordeaux classification : Report of eight Korean cases. / Kim, Hyunchul; Jang, Ja June; Kim, Dong-Sik; Yeom, Beom Woo; Won, Nam Hee.

In: Korean Journal of Pathology, Vol. 47, No. 5, 19.11.2013, p. 411-417.

Research output: Contribution to journalArticle

@article{fba2a2cc308a42d5a2c433194fb31078,
title = "Clinicopathological analysis of hepatocellular adenoma according to new Bordeaux classification: Report of eight Korean cases",
abstract = "Background: Hepatocellular adenoma (HCA) is a rare benign tumor of the liver. A subtype classification of HCA (hepatocyte nuclear factor 1α [HNF1α]-mutated, β-catenin-mutated HCA, inflammatory HCA, and unclassified HCA) has recently been established based on a single institutional review of a HCA series by the Bordeaux group. Methods: We used histologic and immunohistochemical parameters to classify and evaluate eight cases from our institution. We evaluated the new classification method and analyzed correlations between our results and those of other reports. Results: Seven of our eight cases showed histologic and immunohistochemical results consistent with previous reports. However, one case showed overlapping histologic features, as previously described by the Bordeaux group. Four cases showed glutamine synthetase immunohistochemical staining inconsistent with their classification, indicating that glutamine synthetase staining may not be diagnostic for {\ss}-catenin-mutated HCA. HNF1α-mutated HCA may be indicated by the absence of liver fatty acid binding protein expression. Detection of amyloid A may indicate inflammatory HCA. HCA with no mutation in the HNF1α or β-catenin genes and no inflammatory protein expression is categorized as unclassified HCA. Conclusions: Although the new classification is now generally accepted, validation through follow-up studies is necessary.",
keywords = "Adenoma, Beta catenin, Hepatocyte nuclear factor 1-alpha, Liver cell, Serum amyloid A protein, Subtype",
author = "Hyunchul Kim and Jang, {Ja June} and Dong-Sik Kim and Yeom, {Beom Woo} and Won, {Nam Hee}",
year = "2013",
month = "11",
day = "19",
doi = "10.4132/KoreanJPathol.2013.47.5.411",
language = "English",
volume = "47",
pages = "411--417",
journal = "Journal of Pathology and Translational Medicine",
issn = "2383-7837",
publisher = "Korean Society of Pathologists",
number = "5",

}

TY - JOUR

T1 - Clinicopathological analysis of hepatocellular adenoma according to new Bordeaux classification

T2 - Report of eight Korean cases

AU - Kim, Hyunchul

AU - Jang, Ja June

AU - Kim, Dong-Sik

AU - Yeom, Beom Woo

AU - Won, Nam Hee

PY - 2013/11/19

Y1 - 2013/11/19

N2 - Background: Hepatocellular adenoma (HCA) is a rare benign tumor of the liver. A subtype classification of HCA (hepatocyte nuclear factor 1α [HNF1α]-mutated, β-catenin-mutated HCA, inflammatory HCA, and unclassified HCA) has recently been established based on a single institutional review of a HCA series by the Bordeaux group. Methods: We used histologic and immunohistochemical parameters to classify and evaluate eight cases from our institution. We evaluated the new classification method and analyzed correlations between our results and those of other reports. Results: Seven of our eight cases showed histologic and immunohistochemical results consistent with previous reports. However, one case showed overlapping histologic features, as previously described by the Bordeaux group. Four cases showed glutamine synthetase immunohistochemical staining inconsistent with their classification, indicating that glutamine synthetase staining may not be diagnostic for ß-catenin-mutated HCA. HNF1α-mutated HCA may be indicated by the absence of liver fatty acid binding protein expression. Detection of amyloid A may indicate inflammatory HCA. HCA with no mutation in the HNF1α or β-catenin genes and no inflammatory protein expression is categorized as unclassified HCA. Conclusions: Although the new classification is now generally accepted, validation through follow-up studies is necessary.

AB - Background: Hepatocellular adenoma (HCA) is a rare benign tumor of the liver. A subtype classification of HCA (hepatocyte nuclear factor 1α [HNF1α]-mutated, β-catenin-mutated HCA, inflammatory HCA, and unclassified HCA) has recently been established based on a single institutional review of a HCA series by the Bordeaux group. Methods: We used histologic and immunohistochemical parameters to classify and evaluate eight cases from our institution. We evaluated the new classification method and analyzed correlations between our results and those of other reports. Results: Seven of our eight cases showed histologic and immunohistochemical results consistent with previous reports. However, one case showed overlapping histologic features, as previously described by the Bordeaux group. Four cases showed glutamine synthetase immunohistochemical staining inconsistent with their classification, indicating that glutamine synthetase staining may not be diagnostic for ß-catenin-mutated HCA. HNF1α-mutated HCA may be indicated by the absence of liver fatty acid binding protein expression. Detection of amyloid A may indicate inflammatory HCA. HCA with no mutation in the HNF1α or β-catenin genes and no inflammatory protein expression is categorized as unclassified HCA. Conclusions: Although the new classification is now generally accepted, validation through follow-up studies is necessary.

KW - Adenoma

KW - Beta catenin

KW - Hepatocyte nuclear factor 1-alpha

KW - Liver cell

KW - Serum amyloid A protein

KW - Subtype

UR - http://www.scopus.com/inward/record.url?scp=84887548055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887548055&partnerID=8YFLogxK

U2 - 10.4132/KoreanJPathol.2013.47.5.411

DO - 10.4132/KoreanJPathol.2013.47.5.411

M3 - Article

VL - 47

SP - 411

EP - 417

JO - Journal of Pathology and Translational Medicine

JF - Journal of Pathology and Translational Medicine

SN - 2383-7837

IS - 5

ER -